Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Seizure Semiology in Antibody-Associated Autoimmune EncephalitisTillman Kaaden, Marie Madlener, Klemens Angstwurm, et al.
Annals of Neurology|November 6, 2015
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment coursesIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2016
Influence of female sex and fertile age on neuromyelitis optica spectrum disordersNadja Borisow, Ingo Kleiter, Anna Gahlen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.
JAMA Neurology|August 7, 2023
Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System DemyelinationAna Beatriz Ayroza Galvão Ribeiro Gomes, Laila Kulsvehagen, Patrick Lipps, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2026
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGADThivya Pakeerathan, James Davis, Amanda D Henderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromesSumanta Barman, Saskia Räuber, Katharina Eisenhut, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.
Annals of Clinical and Translational Neurology|November 17, 2025
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis OpticaHadi Salih, Sara Samadzadeh, Charlotte Bereuter, et al.
Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.
Pageof 12